A
Akumin Inc
NASDAQ:AKU
Akumin Inc
NASDAQ:AKU
Price:
0.33 USD
Updated:
May 2, 2024
Akumin Inc
Revenue
|
Akumin Inc
Revenue Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Akumin Inc
NASDAQ:AKU
|
Revenue
$749.6m
|
CAGR 3-Years
50%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
Akumin Inc
Revenue Breakdown
Breakdown by Geography
Akumin Inc
Akumin Inc
Not Available
Breakdown by Segments
Akumin Inc
Akumin Inc
|
Total Revenue:
749.6m
USD
|
|
Radiology:
624.8m
USD
|
|
Oncology:
124.8m
USD
|
See Also
What is Akumin Inc's Revenue?
Revenue
749.6m
USD
749.6m
USD
Based on the financial report for Dec 31, 2022, Akumin Inc's Revenue amounts to 749.6m USD.
What is Akumin Inc's Revenue growth rate?
Revenue CAGR 5Y
47%
47%
Over the last year, the Revenue growth was 78%. The average annual Revenue growth rates for Akumin Inc have been 50% over the past three years , 47% over the past five years .
You don't have any saved screeners yet
